Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, M
about
Catastrophic relapse of Evans syndrome five years after allogeneic BMT notwithstanding full donor chimerism. Terminal hemolytic-uremic syndrome.Hematopoietic stem cell transplantation for multiple sclerosis: collaboration of the CIBMTR and EBMT to facilitate international clinical studies.Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosis.Haematopoietic stem cell transplantation for autoimmune diseases.Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go?Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a rImmunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005Cell therapy for autoimmune diseasesHaematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow TransplantationHematopoietic cell transplantation for autoimmune disease: updates from Europe and the United States."Regulating" rheumatoid arthritis via autotransplantation.Emerging therapies for multiple sclerosis.Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research.Hematopoietic SCT for the treatment of multiple sclerosis.Autologous hematopoietic cell transplantation for multiple sclerosis: a systematic review.Hematopoietic stem cell transplantation for curing children with severe autoimmune diseases: is this a valid option?The role of donor-derived veto cells in nonmyeloablative haploidentical HSCT.Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis.Allogeneic hematopoietic SCT for patients with autoimmune diseases.Allogeneic hematopoietic stem cell transplantation for severe autoimmune diseases.Multiple sclerosis conference synopsis and discussion: cellular therapy for treatment of autoimmune diseases (October 2005).The origin of increasing utilization of hematopoietic stem cell transplantation (HSCT) for severe autoimmune diseases (SAD). Introduction.[Allogeneic stem cell transplantation : An option for autoimmune diseases?]Hematopoietic stem cell transplantation for systemic lupus erythematosus
P2860
Q33373065-94C7A5F6-D18B-43DA-8170-738D54F31857Q33965239-5D8F7422-DAF6-44C2-BCB5-41273E9FB519Q34207677-7D1EE969-D22E-49E6-B6F8-CE5ED7092ABCQ34551863-9BA332A6-AD13-4A39-A0B0-34079CB1D94AQ35594089-7E0833F5-29FF-4170-96FE-1B0147289E2BQ35638755-21B56963-B6C5-4159-91E1-BCA706312D06Q35769026-943116B4-2625-4909-BCD4-E3DA3B8D5CD3Q35868954-E62CB3CF-3954-42D8-9B5D-5ED698FA4977Q36020897-0A925896-B232-4969-B21B-8370953822A3Q36252940-745241B0-A1AE-4381-8872-6D3A9AF1726AQ36657964-53F53C36-F51B-4C08-B687-60A36BF0877FQ36963208-62E7C71D-4B43-4AE3-A456-CAF2A73865A4Q37632215-E7B02971-CF14-4FC1-A604-71EF538490B0Q37778984-D779CF28-0B59-4358-8617-ECC7B25AD11EQ37797809-8C99E843-AF21-4450-9F62-47DAE3453248Q38004048-A1495197-38DD-4901-8864-B9884DF5A01DQ38514485-78660099-B999-4460-BC9C-BF27CFB6F7A9Q39378263-8870CED0-9DC5-442B-B62F-7B26A5AC2E00Q39869160-811F538E-8888-4045-BCEA-B1B9B999C0D0Q44158688-986008E4-F20D-4564-8E72-C162DEB25315Q47581830-B42EAE29-B06B-4B0C-AF0A-EB09BD049A13Q53443452-7443B13A-98DE-4537-B3AC-78E1BE4F919EQ53923462-BEB79AFD-6F2C-4A08-83AC-F97562AACEA5Q58908910-E3BA2784-1667-4840-9E29-BA28F9A3570D
P2860
Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, M
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Feasibility of allogeneic hema ...... onal Workshop, Bethesda, MD, M
@ast
Feasibility of allogeneic hema ...... onal Workshop, Bethesda, MD, M
@en
type
label
Feasibility of allogeneic hema ...... onal Workshop, Bethesda, MD, M
@ast
Feasibility of allogeneic hema ...... onal Workshop, Bethesda, MD, M
@en
prefLabel
Feasibility of allogeneic hema ...... onal Workshop, Bethesda, MD, M
@ast
Feasibility of allogeneic hema ...... onal Workshop, Bethesda, MD, M
@en
P2093
P50
P1476
Feasibility of allogeneic hema ...... onal Workshop, Bethesda, MD, M
@en
P2093
Alan Tyndall
Christopher N Bredeson
Harry Openshaw
Jacob M van Laar
James D Bowen
Linda M Griffith
Maureen D Mayes
Peter A McSweeney
Riccardo Saccardi
Richard A Nash
P304
P356
10.1016/J.BBMT.2005.07.009
P577
2005-11-01T00:00:00Z